【レポートの概要（一部）】
1. Report Overview
1.1 Global Ophthalmic Drugs Market Overview
1.2 Global Ophthalmic Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Ophthalmic Drugs
2.1 The Pharmaceutical Industry: a Very Brief Overview
2.2 The Eye: An Overview of Its Structure and Function
2.3 The Global Burden of Eye Disease
2.4 Ophthalmic Drugs: Market Segmentation
2.5 Glaucoma: the ‘Silent Thief of Sight’
2.5.1 A Classification of Glaucoma
2.5.1.1 Primary Open-Angle Glaucoma
2.5.1.2 Acute Angle-Closure Glaucoma
2.5.1.3 Congenital Glaucoma
2.5.1.4 Secondary Glaucoma
2.5.1.5 Normal-Tension Glaucoma
2.5.1.6 Ocular Hypertension
2.5.2 Risk Factors for Glaucoma
2.5.3 Diagnosis of Glaucoma
2.5.4 Drug Treatment of Glaucoma
2.5.5 Laser Treatment and Surgery for Glaucoma
2.6 Age-Related Macular Degeneration (AMD)
2.6.1 Dry (non-exudative) AMD
2.6.2 Wet (exudative) AMD
2.6.3 Risk Factors for AMD
2.6.4 Diagnosis of AMD
2.6.5 Treatment of AMD
2.7 Diabetic Retinopathy (DR)
2.7.1 Diagnosis of Diabetic Retinopathy
2.7.2 Treatment of Diabetic Retinopathy
2.8 Ocular Allergy and Allergic Conjunctivitis
2.8.1 Diagnosis of Ocular Allergy
2.8.2 Treatment of Ocular Allergy
2.9 Ocular Inflammatory Disease
2.9.1 Treatment of Ocular Inflammatory Disease
2.10 Eye Infections
2.10.1 Treatment of Eye Infections
2.11 Dry Eye Syndrome
2.11.1 Treatment of Dry Eye Syndrome
2.12 Phases of Clinical Trials
2.13 Scope of this Report
2.14 Currency Exchange Rates in This Report
3. Ophthalmic Drugs: World Market 2014-2024
3.1 The World Ophthalmic Drugs Market in 2013
3.1.1 Leading Ophthalmic Drugs
3.1.2 Leading Companies in the Ophthalmic Drugs Market
3.2 World Ophthalmic Drugs Market: Sales Forecast 2014-2024
3.3 Retinal Disorder Drugs Lead the World Ophthalmic Drugs Market
3.4 How Will Segmental Market Shares Change to 2024?
3.4.1 World Ophthalmic Drugs Market: Drivers and Restraints 2014-2024
4. Leading National Markets 2014-2024
4.1 Geographical Breakdown of the World Ophthalmic Drugs Market
4.2 World Ophthalmic Drugs Market: National Markets Forecast 2014-2024
4.2.1 How Will National Market Shares Change to 2024?
4.3 The US Ophthalmic Drugs Market 2014-2024
4.3.1 US Ophthalmic Drugs Market Forecast 2014-2024
4.3.2 US Ophthalmic Drugs Market: Trends and Developments
4.3.2.1 Affordable Care Act: Expanding Medicare Coverage
4.3.2.2 A US Biosimilars Market?
4.4 Japanese Ophthalmic Drugs Market 2014-2024
4.4.1 Japanese Ophthalmic Drugs Market Forecast 2014-2024
4.4.2 Japanese Ophthalmic Drugs Market: Trends and Developments
4.4.2.1 The Cost of Treatment in Japan
4.5 Chinese Ophthalmic Drugs Market 2014-2024
4.5.1 Chinese Ophthalmic Drugs Market Forecast 2014-2024
4.5.2 Chinese Ophthalmic Drugs Market: Trends and Developments
4.5.2.1 Expansion of Healthcare Coverage and Reimbursement
4.5.2.2 Price Controls and the Anhui Model
4.6 EU5 Ophthalmic Drugs Market 2014-2024
4.6.1 German Ophthalmic Drugs Market Forecast 2014-2024
4.6.2 French Ophthalmic Drugs Market Forecast 2014-2024
4.6.3 UK Ophthalmic Drugs Market Forecast 2014-2024
4.6.4 Italian Ophthalmic Drugs Market Forecast 2014-2024
4.6.5 Spanish Ophthalmic Drugs Market Forecast 2014-2024
4.7 Brazilian Ophthalmic Drugs Market 2014-2024
4.7.1 Brazilian Ophthalmic Drugs Market Forecast 2014-2024
4.7.2 Brazilian Ophthalmic Drugs Market: Trends and Developments
4.7.2.1 Increasing Access to Medicines
4.8 Russian Ophthalmic Drugs Market 2014-2024
4.8.1 Russian Ophthalmic Drugs Market Forecast 2014-2024
4.8.2 Russian Ophthalmic Drugs Market: Trends and Developments
4.8.2.1 Pharma2020, Healthcare and Industry Reform
4.9 Indian Ophthalmic Drugs Market 2014-2024
4.9.1 Indian Ophthalmic Drugs Market Forecast 2014-2024
4.9.2 Indian Ophthalmic Drugs Market: Trends and Developments
4.9.2.1 Drug Prices Control Order 2013
4.9.2.2 Expansion of Healthcare Provision
4.10 Mexican Ophthalmic Drugs Market 2014-2024
4.10.1 Mexican Ophthalmic Drugs Market Forecast 2014-2024
4.10.2 Mexican Ophthalmic Drugs Market: Trends and Developments
4.10.2.1 Lupin Acquires Laboratorios Grin, Entering the Mexican Market
4.10.2.2 Seguro Popular: Mexican Healthcare Reform
4.10.2.3 International Interest in Mexico
5. Retinal Disorder Drugs Market 2014-2024
5.1 Retinal Disorder Drugs: the Rise of Anti-VEGF Therapy
5.2 Leading Retinal Disorder Drugs in 2013
5.3 Retinal Disorder Drugs: Market Forecast 2014-2024
5.4 Market Share of Leading Retinal Disorder Drugs to 2024
5.5 Retinal Disorder Drugs: Trends and Developments
5.5.1 Lucentis Dominates the Retinal Disorder Drugs Market
5.5.2 Roche and Novartis Fined Over Lucentis-Avastin Collusion
5.5.3 Requiring Avastin Use in AMD?
5.5.4 Novartis Licenses Ophthotech’s Fovista
5.5.5 Jetrea Launch Disappoints Analysts
5.5.6 Conbercept Approved in China
5.5.7 Drug/Device Combination Products Entering the Market
5.5.8 Advances in Regenerative Medicine
5.6 Lucentis (ranibizumab, Roche/Novartis)
5.6.1 Lucentis: Sales Forecast 2014-2024
5.6.2 Less Frequent Dosing Approved in US
5.6.3 New Indications for Lucentis
5.6.4 Lucentis/Fovista Combination Therapy?
5.7 Eylea (aflibercept, Regeneron/Bayer/Santen)
5.7.1 Eylea: Sales Forecast 2014-2024
5.7.2 The Comparative Efficacy of Eylea
5.7.3 Combination Therapy with Eylea and a PDGFR-beta Inhibitor
5.8 Avastin (bevacizumab, Roche)
5.8.1 Avastin: Sales Forecast 2014-2024
5.8.2 Compounding Pharmacies and Safety Risks
5.9 Visudyne (verteporfin, Valeant/Novartis)
5.9.1 Visudyne: Sales Forecast 2014-2024
5.10 Jetrea (ocriplasmin, ThromboGenics/Novartis)
5.10.1 Jetrea: Sales Forecast 2014-2024
5.10.2 Potential Acquisition of ThromboGenics?
5.10.3 R&D Agreements with Eleven Biotherapeutics and Bicycle Therapeutics
5.11 Other Retinal Disorder Drugs
5.11.1 Iluvien (fluocinolone implant, Alimera Sciences)
5.11.2 Ozurdex (dexamethasone implant, Allergan)
6. Allergic, Inflammatory and Infective Drugs Market 2014-2024
6.1 Allergic, Inflammatory and Infective Drugs: Introduction
6.2 Allergic, Inflammatory and Infective Drugs: Submarket Breakdown
6.3 Leading Allergic, Inflammatory and Infective Drugs in 2013
6.4 Allergic, Inflammatory and Infective Drugs: Market Forecast 2014-2024
6.5 Market Share of Leading Allergic, Inflammatory and Infective Drugs to 2024
6.6 Allergic, Inflammatory and Infective Drugs: Trends and Developments
6.6.1 Growth Prospects in 2014-2024
6.6.2Lupin Launches Generic Zymaxid
6.6.3 New Topical NSAIDs Launched: Prolensa and Ilevro
6.7 Patanol and Pataday (olopatadine, Alcon)
6.7.1 Patanol: Sales Forecast 2014-2024
6.7.2 Pataday: Sales Forecast 2014-2024
6.7.3 Generic Competition for Patanol/Pataday?
6.8 Vigamox (moxifloxacin, Alcon)
6.8.1 Vigamox: Sales Forecast 2014-2024
6.8.2 Generic Challenges to Vigamox
6.8.3 Moxeza: A Next-Generation Form of Vigamox
6.9 TobraDex (tobramycin/dexamethasone, Alcon)
6.9.1 TobraDex: Sales Forecast 2014-2024
6.9.2 TobraDex ST (Alcon/Novartis)
6.10 Bromday (bromfenac, Valeant)
6.10.1 Bromday: Sales Forecast 2014-2024
6.10.2 Prolensa: A New Formulation of Bromfenac
6.10.3 Competition from Ilevro/Nevanac
6.11 Cravit (levofloxacin, Santen)
6.11.1 Cravit: Sales Forecast 2014-2024
6.12 Acular (ketorolac, Allergan)
6.12.1 Acular: Sales Forecast 2014-2024
6.13 AzaSite (azithromycin, Akorn)
6.13.1 AzaSite: Sales Forecast 2014-2024
7. Glaucoma Drugs Market 2014-2024
7.1 Glaucoma: Prostaglandin Analogues Lead the Market
7.2 Leading Glaucoma Drugs in 2013
7.3 Glaucoma Drugs: Market Forecast 2014-2024
7.4 Market Share of Leading Glaucoma Drugs to 2024
7.5 Glaucoma Drugs: Trends and Developments
7.5.1 Revenues Threatened by Patent Expiration
7.5.2 Preservative-Free Formulation Trends
7.5.3 Innovation in Treatments for Glaucoma
7.5.4 Simbrinza Launched as First Beta-Blocker-Free Combination
7.6 Lumigan and Ganfort (bimatoprost, Allergan)
7.6.1 Lumigan and Ganfort: Sales Forecast 2014-2024
7.7 Xalatan and Xalacom (latanoprost, Pfizer)
7.7.1 Xalatan/Xalacom: Sales Forecast 2014-2024
7.8 Travatan/Travatan Z and DuoTrav (travoprost, Novartis)
7.8.1 Travatan/Travatan Z and DuoTrav: Sales Forecast 2014-2024
7.9 Alphagan/Alphagan P and Combigan (brimonidine, Allergan)
7.9.1 Alphagan/Alphagan P and Combigan: Sales Forecast 2014-2024
7.10 Trusopt and Cosopt/Cosopt PF (dorzolamide, Merck)
7.10.1 Trusopt: Sales Forecast 2014-2024
7.10.2 Cosopt and Cosopt PF: Sales Forecast 2014-2024
7.11 Azopt (brinzolamide, Novartis)
7.11.1 Azopt: Sales Forecast 2014-2024
7.12 Tapros (tafluprost, Santen)
7.12.1 Tapros/Taflotan: Sales Forecast 2014-2024
7.13 Zioptan (tafluprost, Akorn)
7.13.1 Zioptan: Sales Forecast 2014-2024
8. Dry Eye Drugs Market 2014-2024
8.1 Dry Eye: Introduction
8.2 Leading Dry Eye Drugs in 2013
8.3 Dry Eye Drugs: Market Forecast 2014-2024
8.4 Market Share of Leading Dry Eye Drugs to 2024
8.5 Dry Eye Drugs: Trends and Developments
8.5.1 Will Generic Restasis Launch in 2014?
8.5.2 Intensive Research Focus on Dry Eye
8.5.3 Improving Diagnostic Tools
8.6 Restasis (ciclosporin, Allergan)
8.6.1 Restasis: Sales Forecast 2014-2024
8.7 Refresh Brand Products (Allergan)
8.7.1 Refresh Brand Products: Sales Forecast 2014-2024
8.8 Hyalein (hyaluronic acid, Santen)
8.8.1 Hyalein: Sales Forecast 2014-2024
8.9 Diquas (diaquafosol, Santen)
8.9.1 Diquas: Sales Forecast 2014-2024
8.10 Other Ophthalmic Drugs
8.10.1 Hetlioz (tasimelteon, Vanda Pharmaceuticals)
8.10.2 Hetlioz: Sales Forecast 2014-2024
9. Leading Companies in the Ophthalmic Drugs Market
9.1 Novartis (Alcon)
9.1.1 Novartis: Ophthalmic Drugs Portfolio
9.1.2 Novartis: Sales Forecast 2014-2024
9.1.3 Novartis: Products in Development
9.1.4 Novartis: Recent Developments
9.1.4.1 Novartis Restructures Following Strategic Review
9.1.4.2 Novartis Licenses Ophthothech’s Fovista
9.2 Allergan
9.2.1 Allergan: Ophthalmic Drugs Portfolio
9.2.2 Allergan: Sales Forecast 2014-2024
9.2.3 Allergan: Products in Development
9.2.3.1 Novadur (Intravitreal Brimonidine Implant)
9.2.4 Allergan: Recent Developments
9.2.4.1 Ozurdex (Dexamethasone Intravitreal Implant): The First Drug Therapy for Diabetic Macular Oedema
9.2.4.2 Prospects for Generic Restasis?
9.2.4.3 Allergan Rejects Valeant Bid
9.2.4.4 Allergan Considering Acquiring Shire?
9.3 Roche
9.3.1 Roche: Ophthalmic Drugs Portfolio
9.3.1.1 Lucentis: US Sales Forecast 2014-2024
9.3.2 Roche: Sales Forecast 2014-2024
9.3.3 Roche: Products in Development
9.4 Valeant
9.4.1 Valeant: Ophthalmic Drugs Portfolio
9.4.2 Valeant: Sales Forecast 2014-2024
9.4.3 Valeant: Products in Development
9.4.4 Valeant: Recent Developments
9.4.4.1 Valeant’s Acquisition of Bausch and Lomb: Aggressive Expansion?
9.4.4.2 Bausch and Lomb Had Acquired ISTA Pharmaceuticals
9.5 Regeneron
9.5.1 Regeneron: Ophthalmic Drugs Portfolio
9.5.2 Regeneron: Sales Forecast 2014-2024
【レポート販売概要】
■ タイトル：世界の眼科医薬品市場予測：網膜疾患/アレルギー性炎症/緑内障/眼球乾燥症治療薬■ 英文：Ophthalmic Drugs Market Forecast 2014-2024
Prospects for Leading Companies
■ 発行日：2014年6月
■ 調査会社：visiongain
■ 商品コード：VISG409051
■ 調査対象地域：グローバル
- 架空ケーブルの世界市場2017-2021ABSTRACTAbout Overhead Cables Cables are a collection of electrical conductors that are insulated. These are used for transmission and distribution purposes. Overhead cables are installed above buildings and between electric poles. There is a presumption that underground cables are more reliable as they are less prone to damage from storms, lightning, and other disruptions. However, underground ca …
- クラウド型インサイトサービスの世界市場予測（～2021）The Insights-as-a-Service market is expected to grow from USD 1.16 Billion in 2016 to USD 3.33 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 23.5% during the forecast period. The major drivers of this market include better business with new revenue streams, increasing focus on cloud deployment model, and rising need for understanding customer behavior to focus on marketing and sales …
- 世界のメイクアップ市場：ニュース、イベント動向（2014年3月）Synopsis The report provides a review of the latest news and key events in the global make-up market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global make-up market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global make- …
- 世界のタンパク成分市場調査レポート：Global Protein Ingredient Market 2014-2018TechNavio's analysts forecast the Global Protein Ingredient market to grow at a CAGR of 6.03 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing global health-conscious population. The Global Protein Ingredient market has also been witnessing the growth in the Food and Beverage industry. However, the low awareness rate could pose a challenge …
- エリスロポエチンのグローバル市場動向Erythropoietin (EPO) treatment is an innovative technique to regulate red blood cells in a human body. The global erythropoietin industry has been languishing over the past few years and presenting very limited opportunities to the industry players. However, with favourable demographics, positive eco-financial dynamics, rising incidence of cancer and anemia, and rising awareness, the global erythr …
- ポリスチレン(PS)の世界市場予測Plystyrene 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about plystyrene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, th …
- 包装産業向けアルミニウムの世界市場2017-2021About Aluminum Market for Packaging Industry The global aluminum packaging market includes aluminum sheets, foils, and other aluminum product types for packaging. Aluminum products for packaging are used for their flexibility, durability, and sustainability in applications such as consumer packaging and pharmaceutical packaging. Aluminum products are preferred for packaging because they do not emi …
- 小児てんかん治療薬の世界市場2019-2023107 pages, November 2018 About this market The emergence of biomarkers to gain traction in the market. The world of epilepsy diagnostics is experiencing a trend of emerging biomarkers for epileptogenesis. Epilepsy is the disorder of repeated seizures; hence, these biomarkers for epileptogenesis are used to identify the spontaneity of the seizures. Technavio’s analysts have predicted that the pedia …
- 世界の幹細胞抗がん治療市場動向（2012-2016）TechNavio's analysts forecast the Global Stem Anticancer Therapeutics market to grow at a CAGR of 11.48 percent over the period 2012-2016. Increasing investment in R&D is one of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval …
- Southwestern Energy Company：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Southwestern Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Southwestern Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 小売産業におけるM2Mサービス市場About M2M Services In the Retail industry, M2M services are used for real-time payments and transactions. This technology is used in vending machines to track purchases, inventory level, and sales from a remote location and also in ATMs, parking meters, transport management, smart cashier management, security and surveillance, and customer analysis. Financial institutions and banks use M2M technol …
- 荷役機械の世界市場分析：製品別（貯蔵･取扱機器、自動貯蔵･回収システム、産業用トラック、バルク材料処理機器）、地域別、セグメント予測、2014-2025The global material handling equipment market is expected to reach USD 41.1 billion by 2025, according to a new report conducted by Grand View Research, Inc. The rise in manufacturing activities in the automotive, pharmaceutical, chemical, and food & beverage industries is projected to spur demand. The growing concerns for workplace safety are expected to remain a key driver. The global material h …
- Aricept (Alzheimer’s Disease)：市場予測と分析（～2022）Aricept (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Aricept (Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are …
- ソーシャルゲームの世界市場2015-2019About social gaming Social gaming is the activity of playing games on social media platforms, networking sites, or within social media applications. It gained popularity when the social networking major Facebook and Zynga collaborated in 2009 to offer Farmville on the social networking site. Following the success of Farmville on Facebook, social gaming became popular worldwide. Technavio's analyst …
- 生検装置の世界市場：企業動向Biopsy Devices - Current and Future Players Summary Cancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer d …
